Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients

AIDS

Volumn 17, Issue SUPPL. 1, 2003, Pages

  Johnson, Raymond M ^a   Barbarini, Giorgio ^b   Barbaro, Giuseppe ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Erythema elevatum diutinum; HIV; Kawasaki; Polyangiitis; Polyarteritis nodosa; Primary angiitis of the central nervous system; Vasculitis

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIVIRUS AGENT; COTRIMOXAZOLE; DELAVIRDINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; TENOFOVIR;

ACUTE HEART INFARCTION; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; ARTERY OCCLUSION; BEHCET DISEASE; CAUSE OF DEATH; CERVICAL LYMPH NODE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONJUNCTIVITIS; CONVALESCENCE; CORONARY ARTERY ANEURYSM; CRYOGLOBULINEMIA; DRUG HYPERSENSITIVITY; ERYTHEMA; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LYMPHADENOPATHY; MORBIDITY; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PERIPHERAL EDEMA; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; RASH; REVIEW; TEMPORAL ARTERITIS; TOXOPLASMA GONDII; VASCULITIS; VIRUS REPLICATION; VIRUS RESISTANCE; WEGENER GRANULOMATOSIS;

EID: 0037866736     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304001-00011     Document Type: Review

References (66)

1. Munoz Fernandez S, Cardenal A, Balsa A, et al. Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Semin Arthritis Rheum 1991, 21:30-39.
2. Gisselbrecht M, Cohen P, Lortholary O, et al. HIV-related vasculitis: clinical presentation and therapeutic approach on six patients. AIDS 1997, 11:121-123.
3. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000, 30:147-166.
4. Shingadia D, Das L, Klein-Gitelman M, Chadwick E. Takayasu's arteritis in a human immunodeficiency virus-infected adolescent. Clin Infect Dis 1999, 29:458-459.
5. Stein CM, Thomas JE. Behçet's disease associated with HIV infection. J Rheumatol 1991, 18:1427-1428.
6. Buskila D, Gladman DD, Gilmore J, Salit IE. Behçet's disease in a patient with immunodeficiency virus infection. Ann Rheum Dis 1991, 50:115-116.
7. Cooper LM, Patterson JA. Allergic granulomatosis and angiitis of Churg-Strauss. Case report in a patient with antibodies to human immunodeficiency virus and hepatitis B virus. Int J Dermatol 1989, 28:597-599.
8. Hall TN, Brennan B, Leahy MF, Woodroffe AJ. Henoch-Schönlein purpura associated with human immunodeficiency virus infection. Nephrol Dial Transplant 1998, 13:988-990.
9. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinico-pathologic evaluation. Arthritis Rheum 1993, 36:1164-1174.
10. Koopmans PP, van der Ven AJ, Vree TB, van der Meer JW. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS 1995, 9:217-222.
11. Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997, 52:388-393.
12. Coleman JW. Protein haptenation by drugs. Clin Exp Allergy 1998, 28(suppl 4):79-82.
13. Park BK, Naisbitt DJ, Gordon SF, Kitteringham NR, Pirmohamed M. Metabolic activation in drug allergies. Toxicology 2001, 158:11-23.
14. Claudy A. Pathogenesis of leukocytoclastic vasculitis. Eur J Dermatol 1998, 8:75-79.
15. Hewitt RG. Abacavir hypersensitivity reaction. Clin Infect Dis 2002, 34:1137-1142.
16. Hetherington S, Hughes AR, Mosteller M, et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002, 359:1121-1122.
17. Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002, 359:727-732.
18. Golden MP, Hammer SM, Wanke CA, Albrecht MA. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine (Baltimore) 1994, 73:246-255.
19. Huang TE, Chou SM. Occlusive hypertrophic arteritis as the cause of discrete necrosis in CNS toxoplasmosis in the acquired immunodeficiency syndrome. Hum Pathol 1988, 19:1210-1214.
20. Liu YC, Tomashefski JF Jr, Tomford JW, Green H. Necrotizing Pneumocystis carinii vasculitis associated with lung necrosis and cavitation in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1989, 113:494-497.
21. Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med 1967, 43:8-14.
22. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.
23. Font C, Miro O, Pedrol E, et al. Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. Br J Rheumatol 1996, 35:796-799.
24. Sams WM Jr. Necrotizing vasculitis. J Am Acad Dermatol 1980, 3:1-13.
25. Gupta S, Piraka C, Jaffe M. Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B. N Engl J Med 2001, 344:1645-1646.
26. Pillay D, Cane PA, Ratcliffe D, Atkins M, Cooper D. Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR coordinating committee. AIDS 2000, 14:1111-1116.
27. Serfaty L, Thabut D, Zoulim F, et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. Hepatology 2001, 34:573-577.
28. de Man RA, Marcellin P, Habal F, Desmond P, Wright T, Rose T, Jurewicz R, Young C. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B and antigen-positive hepatitis B. Hepatology 2000, 32:413-417.
29. Ying C, De Clercq E, Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. J Viral Hepat 2000, 7:79-83.
30. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992, 15:578-583.
31. Lie JT. Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992, 23:164-171.
32. Calabrese LH. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 1991, 17:131-147.
33. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988, 67:20-39.
34. Cupps TR, Moore PM, Fauci AS. Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience. Am J Med 1983, 74:97-105.
35. Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987, 106:19-26.
36. da Cunha Bang F, Weismann K, Ralfkiaer E, Pallesen G, Lange Wantzin G. Erythema elevatum diutinum and pre-AIDS. Acta Derm Venereol 1986, 66:272-274.
37. Requena L, Sanchez Yus E, Martin L, Barat A, Arias D. Erythema elevatum diutinum in a patient with acquired immunodeficiency syndrome. Another clinical simulator of Kaposi's sarcoma. Arch Dermatol 1991, 127;1819-1822.
38. LeBoit PE, Cockerell CJ. Nodular lesions of erythema elevatum diutinum in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1993, 28:919-922.
39. Bachmeyer C, Aractingi S. Erythema elevatum diutinum with HIV-2 infection. Lancet 1996, 347:1041-1042.
40. Dronda F, Gonzalez-Lopez A, Lecona M, Barros C. Erythema elevatum diutinum in human immunodeficiency virus-infected patients-report of a case and review of the literature. Clin Exp Dermatol 1996, 21:222-225.
41. Revenga F, Vera A, Munoz A, De la Llana FG, Alejo M, Rodriguez-Peralto JL. Erythema elevatum diutinum and AIDS: are they related? Clin Exp Dermatol 1997, 22:250-251.
42. Soni BP, Williford PM, White WL. Erythematous nodules in a patient infected with the human immunodeficiency virus. Erythema elevatum diutinum (EED). Arch Dermatol 1998, 134:232-233, 235-236.
43. Suarez J, Miguelez M, Villalba R. Nodular erythema elevatum diutinum in an HIV-1 infected woman: response to dapsone and antiretroviral therapy. Br J Dermatol 1998, 138:717-718.
44. Sanz-Trelles A, Ayala-Carbonero A, Ojeda-Martos A. Erythema elevatum diutinum in an HIV+ hemophilic patient. Am J Dermatopathol 1999, 21:587-588.
45. Libman BS, Quismorio FP Jr, Stimmler MM. Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. J Rheumatol 1995, 22:351-355.
46. O'Grady NP, Sears CL. Therapeutic dilemmas in the care of a human immunodeficiency virus-infected patient with vasculitis: case report. Clin Infect Dis 1996, 23:659-661.
47. Gherardi RK, Mhiri C, Baudrimont M, Roullet E, Berry JP, Poirier J. Iron pigment deposits, small vessel vasculitis, and erythrophagocytosis in the muscle of human immunodeficiency virus-infected patients. Hum Pathol 1991, 22:1187-1194.
48. Gherardi R, Lebargy F, Gaulard P, Mhiri C, Bernaudin JF, Gray F. Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 1989, 321:685-686.
49. Barbaro G, Barbarini G, Pellicelli AM. HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med 2001, 344:1799-1800.
50. Gupta S, Licorish K. Circulating immune complexes in AIDS. N Engl J Med 1984, 310:1530-1531.
51. Massari M, Salvarani C, Portioli I, Ramazzotti E, Gabbi E, Bonazzi L. Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV. Infection 1996, 24:159-161.
52. Conri C, Mestre C, Constans J, Vital C. Periarteritis nodosa-type vasculitis and infection with human immunodeficiency virus. Rev Med Interne 1991, 12:47-51.
53. Porwancher RSS. Adult Kawasaki disease in HIV-infected patients. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract PoB3821].
54. Martinez-Escribano JA, Redondo C, Galera C, Sanchez-Pedreno P, Abel JL, Frias JF. Recurrent Kawasaki syndrome in an adult with HIV-1 infection. Dermatology 1998, 197:96-97.
55. Wolf CV 2nd, Wolf JR, Parker JS. Kawasaki's syndrome in a man with the human immunodeficiency virus. Am J Ophthalmol 1995, 120:117-118.
56. Porneuf M, Sotto A, Barbuat C, Ribou G, Jourdan J. Kawasaki syndrome in an adult AIDS patient. Int J Dermatol 1996, 35:292-294.
57. Viraben R, Dupre A. Kawasaki disease associated with HIV infection. Lancet 1987, 1:1430-1431.
58. Bayrou O, Phlippoteau C, Artigou C, Haddad T, Leynadier F. Adult Kawasaki syndrome associated with HIV infection and anticardiolipin antibodies. J Am Acad Dermatol 1993, 29:663-664.
59. Yoganathan K, Goodman F, Pozniak A. Kawasaki-like syndrome in an HIV positive adult. J Infect 1995, 30:165-166.
60. Johnson RM, Little JR, Storch GA. Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis 2001, 32:1628-1634.
61. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379-1385.
62. Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997, 159:5946-5955.
63. Rowley AH, Shulman ST, Mask CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000, 182:1183-1191.
64. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001, 166:1334-1343.
65. Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheumatol 2001, 13:35-40.
66. Marks C, Kuskov S. Pattern of arterial aneurysms in acquired immunodeficiency disease. World J Surg 1995, 19:127-132.